Ensitrelvir reduced transmission of SARS-CoV-2 by 67% when given to uninfected household contacts of a person with COVID-19 ...
Ensitrelvir PEP was safe and effective for COVID-19 prevention among household contacts when administered after the onset of symptoms in an index patient.
1don MSN
If the past four decades have taught us anything about HIV, it's to adjust our expectations—despite enormous progress in controlling the virus, no treatment can yet completely eradicate HIV once it ...
according to a study presented at the annual Conference on Retroviruses and Opportunistic Infections, held from March 9 to 12 in San Francisco. Akimasa Fukushi, MD, of Shionogi & Co., Ltd ...
The Citizen on MSN4d
First HIV cure clinical trial in Africa shows promise in womenDar/Nairobi. A ground-breaking HIV clinical trial in Africa has demonstrated that some women can control the virus without ...
Scientists aim to eliminate or reduce hidden traces of HIV in the body so the immune system can keep the virus in check ...
AllAfrica on MSN4d
South Africa: Excitement Builds for Long-Acting TB Treatments, but Research Still At Early StageBoth TB treatment and TB preventive therapy involve taking lots of pills, usually for several months. Researchers are working ...
HealthDay on MSN5d
Ensitrelvir Effectively Prevents Spread of COVID-19 in HouseholdsFor household contacts of individuals with COVID-19, taking ensitrelvir within 72 hours of symptoms is effective at preventing infection and generally well tolerated.
AllAfrica on MSN2d
South Africa Research Grants Potentially on Hold, Says Leaked NIH MemoA leaked memo for grant management staff of the US government’s National Institutes of Health (NIH), dated March 25 and of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback